LAGUNA HILLS, CA and SHANGHAI -  Wallaby Medical ("Wallaby"), a rapidly growing medical device company focused on developing and commercializing medical device products for treating stroke has partnered with Japan Lifeline Co., Ltd. ("JLL"), a publicly-listed medical device manufacturer and distributor with 48 sales offices across Japan, to bring Wallaby's Japan PMDA approved Avenir^® Coil System to the Japanese market. Avenir^® is used in the intravascular embolization of intracranial aneurysms and other neurovascular malformations (such as arteriovenous malformations and arteriovenous fistulas), as well as arterial and venous embolization of peripheral blood vessels.

Stroke accounts for over 125,000 deaths¹ annually in Japan and is one of the leading causes of death. Wallaby's vision is to become the medical technology company which saves the most lives affected by stroke, and thus Japan is one of the most important markets to serve. "We are dedicated to improving stroke patient care and this partnership enables us to cover the entire Japan market immediately. JLL's exceptional reach and relationships mean Japanese physicians will now have the Avenir^® Coil System as the go-to device to deliver the best possible outcome for their patients.", said Michael Alper, CEO, Wallaby Medical.

Avenir^® Coil System is designed with three outstanding features: exceptional complex framing, ultra-soft finishing, and an innovative highly reliable instant detachment system. The proprietary design includes a reduced coil first loop diameter to minimize coil herniation during aneurysm introduction. The exceptional framing effect provides excellent aneurysm wall apposition and implant distribution to facilitate dense packing. In addition, ultra-soft finishing coils manufactured from ultra-fine primary wire enhance softness and conformability, allowing for optimal space seeking capability for the deployed coils to realize higher packing density.

"We are very pleased to bring Wallaby Medical's highly competitive products to the Japanese cerebrovascular treatment field and provide physicians with new treatment options. The Avenir^® Coil System allows us to enter the cerebrovascular area, and also meets the needs of physicians in the abdominal aortic treatment area, where we are already strong. We are confident that our collaboration with Wallaby Medical will be an important milestone in the development of our business", said Keisuke Suzuki, President and CEO of JLL.